aTyr Pharma Inc reports results for the quarter ended in June - Earnings Summary

aTyr Pharma

14/08/2023 13:00

* aTyr Pharma Inc  LIFE.OQ  reported a quarterly adjusted
loss
of 22 cents​​ per share for the quarter ended in June. The mean
expectation of seven analysts for the quarter was for a loss
of 28 cents per share.
    * Reported revenue was zero​; analysts expected $524.29
thousand. 
    * aTyr Pharma Inc's reported EPS for the quarter was a loss
of 22
cents​.
    * The mean earnings estimate of analysts had risen by
about 14.3%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * aTyr Pharma Inc shares had fallen by 7.4% this quarter and
lost 8.7% so far this year.
    * The company reported a quarterly loss of $12.34 million.
    * Wall Street's median 12-month price target for aTyr Pharma
Inc
is $19.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 14 at 12:00 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.28          -0.22          Beat
 Mar. 31 2023      -0.40          -0.29          Beat
 Dec. 31 2022      -0.48          -0.26          Beat
 Sep. 30 2022      -0.46          -0.46          Met